Market Cap ₹208 Cr.
Stock P/E 23.1
P/B 2.5
Current Price ₹84
Book Value ₹ 33.5
Face Value 10
52W High ₹121.9
Dividend Yield 0%
52W Low ₹ 80
Incorporated on July 2010, Yash Optics & Lens Limited is a public technology-driven company specializing in the manufacturing of optical lenses. Over the last 24 years, Yash Optics & Lens has emerged as a leading provider of hi-tech digital vision healthcare solutions across the Indian subcontinent. Company has carved out a niche for its expertise in manufacturing optical lenses and stands at the forefront of delivering these solutions to people of India. With a focus on innovation and quality, Yash Optics & Lens is committed to providing products that meet the highest standards of the optical industry without compromising on the commitment.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|
Net Sales | 15 | 30 | 40 | 41 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 15 | 30 | 40 | 41 | |
Total Expenditure | 13 | 20 | 27 | 27 | |
Operating Profit | 2 | 10 | 13 | 15 | |
Interest | 1 | 1 | 1 | 2 | |
Depreciation | 0 | 1 | 1 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 9 | 11 | 12 | |
Provision for Tax | 0 | 2 | 3 | 3 | |
Profit After Tax | 1 | 7 | 8 | 9 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 7 | 8 | 9 | |
Adjusted Earnings Per Share | 0.6 | 3.8 | 4.5 | 5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 2% | 40% | 0% | 0% |
Operating Profit CAGR | 15% | 96% | 0% | 0% |
PAT CAGR | 13% | 108% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 37% | 60% | 51% | 51% |
ROCE Average | 33% | 54% | 46% | 46% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Shareholder's Funds | 4 | 11 | 19 | 30 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 6 | 4 | 11 | 17 |
Other Non-Current Liabilities | 0 | 0 | 1 | 1 |
Total Current Liabilities | 2 | 9 | 3 | 13 |
Total Liabilities | 12 | 24 | 34 | 61 |
Fixed Assets | 0 | 4 | 8 | 19 |
Other Non-Current Assets | 0 | 0 | 0 | 8 |
Total Current Assets | 12 | 20 | 26 | 33 |
Total Assets | 12 | 24 | 34 | 61 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 0 | 0 |
Cash Flow from Operating Activities | -0 | 8 | -12 | 3 |
Cash Flow from Investing Activities | -0 | -5 | -8 | -19 |
Cash Flow from Financing Activities | 0 | -2 | 10 | 33 |
Net Cash Inflow / Outflow | 0 | 0 | -11 | 18 |
Closing Cash & Cash Equivalent | 1 | 1 | -11 | 18 |
# | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Earnings Per Share (Rs) | 0.6 | 3.85 | 4.53 | 4.96 |
CEPS(Rs) | 0.65 | 4.19 | 4.93 | 5.44 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 2.41 | 6.24 | 10.75 | 16.39 |
Core EBITDA Margin(%) | 13.74 | 34.35 | 31.42 | 35.52 |
EBIT Margin(%) | 13.3 | 32.66 | 29.89 | 33.63 |
Pre Tax Margin(%) | 9.93 | 30.79 | 27.33 | 29.48 |
PAT Margin (%) | 7.11 | 22.91 | 20.22 | 21.95 |
Cash Profit Margin (%) | 7.67 | 24.97 | 21.97 | 24.07 |
ROA(%) | 8.78 | 37.3 | 27.45 | 19.07 |
ROE(%) | 24.92 | 89.02 | 53.35 | 36.92 |
ROCE(%) | 19.68 | 77.15 | 52.78 | 32.53 |
Receivable days | 99.66 | 72.61 | 77.5 | 92.79 |
Inventory Days | 152.02 | 102.7 | 119.9 | 158.4 |
Payable days | 57.45 | 163.99 | 124.87 | 91.49 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.33 | 0.09 | 0.26 | 1.04 |
EV/Core EBITDA(x) | 2.4 | 0.27 | 0.82 | 2.9 |
Net Sales Growth(%) | 0 | 98.84 | 33.45 | 3.55 |
EBIT Growth(%) | 0 | 388.08 | 22.14 | 16.48 |
PAT Growth(%) | 0 | 541.21 | 17.77 | 12.39 |
EPS Growth(%) | 0 | 541.21 | 17.77 | 9.34 |
Debt/Equity(x) | 1.37 | 0.36 | 0.57 | 0.85 |
Current Ratio(x) | 6.49 | 2.19 | 7.48 | 2.49 |
Quick Ratio(x) | 3.09 | 1.03 | 2.99 | 0.98 |
Interest Cover(x) | 3.95 | 17.49 | 11.68 | 8.11 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Sep 2024 |
---|---|
Promoter | 71.63 |
FII | 1.71 |
DII | 0.98 |
Public | 25.69 |
Others | 0 |
Total | 100 |
# | Sep 2024 |
---|---|
Promoter | 1.77 |
FII | 0.04 |
DII | 0.02 |
Public | 0.64 |
Others | 0 |
Total | 2.48 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About